Pages that link to "Q114304275"
Jump to navigation
Jump to search
The following pages link to Jan-Henk E Dambrink (Q114304275):
Displaying 50 items.
- The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616] (Q24813295) (← links)
- Comparison between ticlopidine and clopidogrel in patients with ST-segment elevation myocardial infarction treated with coronary stenting (Q28168833) (← links)
- Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction (Q28193098) (← links)
- Platelet microaggregation inhibition in patients with acute myocardial infarction pretreated with tirofiban and relationship with angiographic and clinical outcome (Q28196842) (← links)
- Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarction (Q28200071) (← links)
- A comparison of dual vs. triple antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndrome: results of the ELISA-2 trial (Q28217702) (← links)
- Feasibility and benefit of prehospital diagnosis, triage, and therapy by paramedics only in patients who are candidates for primary angioplasty for acute myocardial infarction (Q28219216) (← links)
- Are patients with non-ST elevation myocardial infarction undertreated? (Q28219991) (← links)
- Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty (Q28266586) (← links)
- Sex-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty: data from the Zwolle Myocardial Infarction study (Q30975347) (← links)
- Comparison of rapamycin- and paclitaxel-eluting stents in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction (Q33478122) (← links)
- Angiographic Assessment of Reperfusion in Acute Myocardial Infarction by Myocardial Blush Grade (Q34532896) (← links)
- The influence of system delay on 30-day and on long-term mortality in patients with anterior versus non-anterior ST-segment elevation myocardial infarction: a cohort study (Q35399718) (← links)
- Age-dependent differences in diabetes and acute hyperglycemia between men and women with ST-elevation myocardial infarction: a cohort study (Q37008751) (← links)
- Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age. (Q37291898) (← links)
- Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trial (Q37599602) (← links)
- Intralesional abciximab and thrombus aspiration in patients with large anterior myocardial infarction: one-year results from the INFUSE-AMI trial (Q38443687) (← links)
- Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial (Q38474127) (← links)
- Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction (Q39117454) (← links)
- Cardiogenic Shock Predicts Long-term Mortality in Hospital Survivors of STEMI Treated With Primary Percutaneous Coronary Intervention (Q39254683) (← links)
- Fractional Flow Reserve-Guided Deferred Versus Complete Revascularization in Patients With Diabetes Mellitus (Q39403590) (← links)
- Comparison between stenting and balloon angioplasty in patients undergoing primary angioplasty of small coronary vessels (Q40275003) (← links)
- Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplasty (Q40388115) (← links)
- ST-segment elevation resolution and outcome in patients treated with primary angioplasty and glucose-insulin-potassium infusion (Q40411247) (← links)
- Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention (Q40815387) (← links)
- Closure device or manual compression in patients undergoing percutaneous coronary intervention: a randomized comparison (Q42787052) (← links)
- Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial. (Q42872648) (← links)
- Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction (Q43514012) (← links)
- Impact of statin therapy at discharge on 1-year mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty (Q43614416) (← links)
- Impact of ischemic time on post-infarction left ventricular function in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (Q43833632) (← links)
- One year outcomes after glucose-insulin-potassium in ST elevation myocardial infarction. The Glucose-insulin-potassium study II. (Q44214631) (← links)
- Poor outcome after recurrent acute myocardial infarction: A plea for optimal secondary prevention (Q44325221) (← links)
- Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge (Q44353713) (← links)
- Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention (Q44497351) (← links)
- A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes (Q44543368) (← links)
- Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial (Q44574635) (← links)
- Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction (Q44614403) (← links)
- Relation between white blood cell count and final infarct size in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the INFUSE AMI trial). (Q44669901) (← links)
- Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial (Q44894175) (← links)
- Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction (Q45056639) (← links)
- Primary percutaneous coronary intervention for ST-elevation myocardial infarction: from clinical trial to clinical practice (Q45737451) (← links)
- Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial. (Q46114820) (← links)
- Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI. (Q46348115) (← links)
- Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction (Q46420635) (← links)
- Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty (Q46541074) (← links)
- Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction (Q46678655) (← links)
- Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction (Q46723870) (← links)
- Change of white blood cell count more prognostic important than baseline values after primary percutaneous coronary intervention for ST elevation myocardial infarction (Q46829298) (← links)
- Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial (Q47222373) (← links)
- Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial (Q47225900) (← links)